Business Ideas

Glenmark Generics files IPO prospectus with Sebi

Drug maker Glenmark Pharmaceuticals today said its subsidiary Glenmark Generics has filed the draft prospectus with marker regulator Securities and Exchange Board of India (SebiI) for an initial public offer (IPO). - Cost audit should be included in Clause 49: Panel - Bharati expects nod for Great Offshore open offer soon - An exchange of their own - Bharati Shipyard mulls Rs 200-cr capex over two years - Sahara realty arm files IPO prospectus, to raise Rs 3,450 cr - Sebi wants listed firms to provide sufficient info to market "Glenmark Generics, has, on September 30, filed the draft red herring prospectus (DRHP) with Sebi for an Initial Public Offer," Glenmark Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE). Drug maker did not disclose any further details about the public issue.

Add your comment:

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):